
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp is experiencing strong revenue growth, particularly in its Cardio & Vascular segment, which saw a 15% increase in the third quarter of 2025, alongside a solid expectation for continued growth in its Electrophysiology (EP) portfolio. The company's gross margins are projected to remain stable, with estimates of 27.3% for 2025 and 27.0% for 2026, reflecting positive operational efficiency alongside forecasts of $1.87 billion in revenues for 2026, indicating a 1.5% year-over-year increase. Furthermore, Integer is expected to benefit from improved operating cash flow and favorable market conditions in the cardiovascular device sector, supporting enhanced growth prospects and lower leverage ratios moving forward.
Bears say
Integer Holdings Corp is facing challenges in its financial outlook, with 4Q25 revenue estimates adjusted downwards to $460 million, which reflects a mere 2% year-over-year increase and a reduction from previous expectations. Management has also lowered its full-year 2026 organic revenue guidance to a range of flat to 3%, indicating reduced demand for key products and projected flat to declining sales in multiple segments. Furthermore, the company anticipates a near-term revenue decline in 1H26, raising concerns about the sustainability of its growth trajectory amid potential downside revisions if organic growth drivers do not perform as anticipated.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares